No abstract available
Plain language summary
This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.
MeSH terms
-
Child, Preschool
-
Humans
-
Infant
-
Respiratory Syncytial Virus Infections* / prevention & control
-
Respiratory Syncytial Virus Vaccines*
-
Respiratory Syncytial Virus, Human
-
United States
-
Vaccine Efficacy
Substances
-
Respiratory Syncytial Virus Vaccines